血液性恶性瘤中的CAR-T细胞疗法:我们现在在哪里,我们将走向哪里?
Aalia N Khan1, Sweety Asija1, Juber Pendhari1
1Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India.
European journal of haematology
|August 7, 2023
概括
化学抗原受体T细胞 (CAR-T) 疗法对B细胞癌症有希望,但面临挑战. 需要策略来克服不良影响,改善持续性,并降低成本以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体T细胞 (CAR-T) 疗法在治疗复发性/耐药性B细胞恶性瘤方面取得了重大进展.
- 六种CAR-T产品被FDA批准用于淋巴瘤,白血病和髓瘤,证明了临床成功.
研究的目的:
- 审查CAR-T研究的进展情况.
- 确定阻碍血液瘤中CAR-T疗法疗效的关键障碍.
- 讨论克服这些挑战的策略.
主要方法:
- 关于CAR-T疗法研究的文献综述.
- 临床结果和挑战的分析.
- 探索潜在的解决方案和未来的方向.
主要成果:
- 卡特-T疗法在血液性恶性瘤中取得了令人印象深刻的临床结果.
- 显著的挑战包括副作用,治疗持久性差,导致复发的抗原逃逸,以及高治疗成本.
- 目前正在制定各种战略以解决这些局限性.
结论:
- 卡特-T疗法是癌症治疗的强大工具,但它的全部潜力受到几个因素的限制.
- 克服与安全性,有效性和可访问性相关的挑战对于更广泛的患者利益至关重要.
- 持续的研究和战略开发对于推进CAR-T疗法至关重要.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


